Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Dxc Technology Company ( ($DXC) ) has released its Q2 earnings. Here is a breakdown of the information Dxc Technology Company presented to its ...

Discover DXC Technology's Q2 2026 earnings insights, AI-driven strategy, and growth goals for SAP & SaaS revenue.

DXC Technology Company. (DXC) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.93 per share a year ago.

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

Loeb, Affiliated Investigator Angela Parcesepe, Distinguished Professor Denis Nash, and colleagues from the CUNY Institute ...